Search Results - "Meuer, Katrin"
-
1
Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease
Published in Journal of neurochemistry (01-05-2006)“…We have recently shown that the hematopoietic Granulocyte-Colony Stimulating Factor (G-CSF) is neuroprotective in rodent stroke models, and that this action…”
Get full text
Journal Article -
2
Both systemic and local application of granulocyte-colony stimulating factor (G-CSF) is neuroprotective after retinal ganglion cell axotomy
Published in BMC neuroscience (14-05-2009)“…The hematopoietic Granulocyte-Colony Stimulating Factor (G-CSF) plays a crucial role in controlling the number of neutrophil progenitor cells. Its function is…”
Get full text
Journal Article -
3
Application of a blood–brain-barrier-penetrating form of GDNF in a mouse model for Parkinson's disease
Published in Brain research (12-04-2006)“…Glial-cell-line-derived neurotrophic factor (GDNF) promotes mesencephalic dopaminergic neuronal survival in several in vitro and in vivo models. As the demise…”
Get full text
Journal Article -
4
A highly sensitive automated complex running wheel test to detect latent motor deficits in the mouse MPTP model of Parkinson's disease
Published in Experimental neurology (01-05-2007)“…The subchronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridin (MPTP) paradigm is one of the most widely used in vivo models of Parkinson's disease (PD). However,…”
Get full text
Journal Article -
5
Membrane-permeable Bcl-xL prevents MPTP-induced dopaminergic neuronal loss in the substantia nigra
Published in Journal of neurochemistry (01-02-2008)“…The anti-apoptotic Bcl-xL is a promising agent to prevent neurodegeneration in Parkinson's disease, which is characterized by a demise of dopaminergic neurons…”
Get full text
Journal Article -
6
Membrane‐permeable Bcl‐x L prevents MPTP‐induced dopaminergic neuronal loss in the substantia nigra
Published in Journal of neurochemistry (01-02-2008)“…The anti‐apoptotic Bcl‐x L is a promising agent to prevent neurodegeneration in Parkinson’s disease, which is characterized by a demise of dopaminergic…”
Get full text
Journal Article